| Casey E Herrforth, MD | |
|
1024 S Lemay Ave, Fort Collins, CO 80524 | |
| (970) 495-8006 | |
| Not Available |
| Full Name | Casey E Herrforth |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1024 S Lemay Ave, Fort Collins, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295030831 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A115247 (California) | Secondary |
| 207P00000X | Emergency Medicine | 0052636 (Colorado) | Primary |
| Entity Name | Hawaii Emergency Physicians Associated Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801843198 PECOS PAC ID: 2860390283 Enrollment ID: O20040127001137 |
News Archive
A UK academic is calling for a nationwide study into the effects traffic pollution has on asthma sufferers after his own research in Cairo highlighted health problems in children who may even be affected while still in the womb.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a prototype methionine aminopeptidase 2 inhibitor, for the treatment of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the regulation of fat metabolism and food intake, and normalizes glucose tolerance in animal models.
A new treatment is among the first known to reduce the severity of acute respiratory distress syndrome caused by the flu in animals, according to a new study.
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
› Verified 2 days ago
| Entity Name | Kau Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144304338 PECOS PAC ID: 7416945548 Enrollment ID: O20040601000398 |
News Archive
A UK academic is calling for a nationwide study into the effects traffic pollution has on asthma sufferers after his own research in Cairo highlighted health problems in children who may even be affected while still in the womb.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a prototype methionine aminopeptidase 2 inhibitor, for the treatment of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the regulation of fat metabolism and food intake, and normalizes glucose tolerance in animal models.
A new treatment is among the first known to reduce the severity of acute respiratory distress syndrome caused by the flu in animals, according to a new study.
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
› Verified 2 days ago
| Entity Name | Hale Ho'ola Hamakua |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164506317 PECOS PAC ID: 7810926029 Enrollment ID: O20200304002483 |
News Archive
A UK academic is calling for a nationwide study into the effects traffic pollution has on asthma sufferers after his own research in Cairo highlighted health problems in children who may even be affected while still in the womb.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a prototype methionine aminopeptidase 2 inhibitor, for the treatment of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the regulation of fat metabolism and food intake, and normalizes glucose tolerance in animal models.
A new treatment is among the first known to reduce the severity of acute respiratory distress syndrome caused by the flu in animals, according to a new study.
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Casey E Herrforth, MD 1024 S Lemay Ave, Fort Collins, CO 80524-3929 Ph: (970) 495-8006 | Casey E Herrforth, MD 1024 S Lemay Ave, Fort Collins, CO 80524 Ph: (970) 495-8006 |
News Archive
A UK academic is calling for a nationwide study into the effects traffic pollution has on asthma sufferers after his own research in Cairo highlighted health problems in children who may even be affected while still in the womb.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a prototype methionine aminopeptidase 2 inhibitor, for the treatment of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the regulation of fat metabolism and food intake, and normalizes glucose tolerance in animal models.
A new treatment is among the first known to reduce the severity of acute respiratory distress syndrome caused by the flu in animals, according to a new study.
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
› Verified 2 days ago
Keasha Nohelani Kuhnen, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1024 S Lemay Ave, Fort Collins, CO 80524 Phone: 303-306-7783 Fax: 303-306-7753 | |
Alexa L Toth, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Pennock Place, Suite 121, Fort Collins, CO 80524 Phone: 970-495-8800 Fax: 970-495-8820 | |
Thomas John Fralich, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1024 S Lemay Ave, Fort Collins, CO 80524 Phone: 303-306-7783 Fax: 303-306-7753 | |
Tyler Creighton Vaughn, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1024 S Lemay Ave, Fort Collins, CO 80524 Phone: 970-495-7000 Fax: 303-306-7753 | |
Jeremy Salsberg, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 S Lemay Ave, Fort Collins, CO 80524 Phone: 970-495-7000 Fax: 970-495-7611 | |
Devin A. Rickett, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 S Lemay Ave, Fort Collins, CO 80524 Phone: 970-495-7000 Fax: 303-306-7753 | |
Shelley W. Moore, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3519 Richmond Dr, Fort Collins, CO 80526 Phone: 970-204-0300 Fax: 970-221-5206 |